Medicine and Dentistry
Cost-Effectiveness Analysis
100%
Treatment Resistant Depression
100%
Quetiapine
100%
Major Depressive Episode
61%
Psilocybine
50%
Placebo
50%
Health Care Cost
33%
Informed Consent
25%
Adverse Event
22%
Depressive Disorder
22%
Montgomery-Åsberg Depression Rating Scale
12%
Biological Marker
12%
Medicine
12%
Tamsulosin
12%
Technology Assessment
11%
Hamilton Rating Scale for Depression
11%
Randomized Controlled Trial
11%
Bipolar Disorder
11%
Personal Experience
11%
DSM-5
11%
Antidepressant
11%
Health Technology
11%
Symptomatology
11%
National Health Service
11%
Intention-to-Treat Analysis
11%
Nursing and Health Professions
Treatment Resistant Depression
100%
Quetiapine
100%
Cost Effectiveness Analysis
100%
Depressive Disorder
22%
Randomization
22%
Adverse Event
22%
Economic Analysis
11%
Socialized Medicine
11%
Intention to Treat Analysis
11%
Biomedical Technology Assessment
11%
Lived Experience
11%
Hamilton Depression Rating Scale
11%
DSM-5
11%
Symptomatology
11%
Antidepressant
11%
Bipolar Disorder
11%
Major Depression
11%
Pharmacology, Toxicology and Pharmaceutical Science
Quetiapine
100%
Treatment Resistant Depression
100%
Adverse Event
22%
Depressive Disorder
22%
Major Depression
11%
Symptomatology
11%
DSM-5
11%
Bipolar Disorder
11%
Antidepressant
11%
Randomized Controlled Trial
11%
Toxic Injury
11%
